Leidos (NYSE:LDOS) Releases FY 2025 Earnings Guidance

Leidos (NYSE:LDOSGet Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 10.350-10.750 for the period, compared to the consensus estimate of 10.570. The company issued revenue guidance of $16.9 billion-$17.3 billion, compared to the consensus revenue estimate of $17.0 billion.

Leidos Trading Down 3.8 %

NYSE:LDOS opened at $137.37 on Wednesday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.15 and a current ratio of 1.23. Leidos has a one year low of $113.67 and a one year high of $202.90. The business’s 50-day simple moving average is $148.78 and its 200 day simple moving average is $157.63. The stock has a market cap of $18.33 billion, a price-to-earnings ratio of 15.65, a price-to-earnings-growth ratio of 0.92 and a beta of 0.66.

Leidos (NYSE:LDOSGet Free Report) last released its quarterly earnings results on Tuesday, February 11th. The aerospace company reported $2.37 EPS for the quarter, topping the consensus estimate of $2.24 by $0.13. Leidos had a return on equity of 30.31% and a net margin of 7.37%. As a group, sell-side analysts predict that Leidos will post 10.03 earnings per share for the current fiscal year.

Leidos Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Friday, March 14th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.16%. The ex-dividend date is Friday, March 14th. Leidos’s dividend payout ratio (DPR) is 18.22%.

Analysts Set New Price Targets

Several brokerages have issued reports on LDOS. Wells Fargo & Company cut their price objective on Leidos from $199.00 to $197.00 and set an “overweight” rating on the stock in a research note on Wednesday. Barclays upped their price objective on Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. TD Cowen cut Leidos from a “buy” rating to a “hold” rating and cut their price objective for the company from $200.00 to $165.00 in a research note on Wednesday, January 8th. Citigroup upped their price objective on Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Finally, Cantor Fitzgerald began coverage on Leidos in a research note on Friday, February 7th. They set an “overweight” rating and a $185.00 price objective on the stock. Five investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $179.33.

Check Out Our Latest Stock Report on LDOS

Insider Activity

In other Leidos news, Director Noel B. Geer acquired 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 20th. The stock was acquired at an average cost of $161.13 per share, with a total value of $322,260.00. Following the acquisition, the director now directly owns 2,000 shares of the company’s stock, valued at $322,260. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.96% of the company’s stock.

Leidos Company Profile

(Get Free Report)

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.

Further Reading

Earnings History and Estimates for Leidos (NYSE:LDOS)

Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.